LOC646736: A Protein Potential Drug Target Or Biomarker (G646736)
LOC646736: A Protein Potential Drug Target Or Biomarker
LOC646736 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the LOC646736 family, which is characterized by the presence of a unique transmembrane domain and a cis-regulated expression pattern.
Recent studies have identified LOC646736 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is because LOC646736 has been shown to play a role in the regulation of cellular processes that are important for disease development, such as cell signaling, angiogenesis, and inflammation.
One of the key functions of LOC646736 is its role in cell signaling. LOC646736 is a positive regulator of the protein Pyh, which is involved in the production of reactive oxygen species (ROS) that can cause damage to cells. Pyh is a transcription factor that is regulated by various factors, including DNA methylation and RNA binding. LOC646736 has been shown to play a role in the regulation of Pyh activity by binding to its nuclear domain and modulating its stability.
In addition to its role in cell signaling, LOC646736 has also been shown to be involved in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed in the body, and it is a critical process for the development and maintenance of tissues. LOC646736 has been shown to play a role in the regulation of angiogenesis by controlling the production of new blood vessels and the formation of blood-brain barriers.
Another function of LOC646736 is its role in inflammation. Inflammation is a critical response of the immune system to harmful stimuli, and it can lead to a range of diseases, including cancer and neurodegenerative diseases. LOC646736 has been shown to play a role in the regulation of inflammation by controlling the production of pro-inflammatory cytokines and the recruitment of immune cells to the site of inflammation.
Due to its involvement in these critical cellular processes, LOC646736 has potential as a drug target or biomarker for a variety of diseases. For example, LOC646736 has been shown to be a potential drug target for cancer, as it has been shown to promote the growth and survival of cancer cells. In addition, LOC646736 has also been shown to be a potential biomarker for neurodegenerative diseases, as it has been shown to be affected in the brains of individuals with neurodegenerative diseases.
LOC646736 is also a potential drug target for cardiovascular diseases, as it has been shown to play a role in the regulation of blood pressure and cholesterol levels. In addition, LOC646736 has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of blood vessels, such as the formation of blood clots and the regulation of cell proliferation.
In conclusion, LOC646736 is a protein that is expressed in various tissues of the body and plays a critical role in several cellular processes that are important for disease development. As a potential drug target or biomarker, LOC646736 has the potential to be a valuable tool for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of LOC646736 in disease and to develop effective treatments.
Protein Name: Uncharacterized LOC646736
The "LOC646736 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC646736 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1 | LOXL2 | LOXL3 | LOXL4 | LPA | LPAL2 | LPAR1 | LPAR2 | LPAR3 | LPAR4 | LPAR5 | LPAR6 | LPCAT1 | LPCAT2 | LPCAT3 | LPCAT4 | LPGAT1 | LPIN1 | LPIN2 | LPIN3
